Clinical Trial Update: Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer [Phase 2]

View source ↗

Summary

This document provides an update on an ongoing Phase 1b/2 clinical trial evaluating SHR-A1811 combinations in advanced HER2-expressing gastric cancer and gastro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: RECRUITING